Agios Pharmaceuticals, Inc. (AGIO): Price and Financial Metrics

Agios Pharmaceuticals, Inc. (AGIO)

Today's Latest Price: $50.66 USD

1.09 (2.20%)

Updated Jun 5 4:00pm

Add AGIO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

AGIO Stock Summary

  • Of note is the ratio of Agios Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; merely 13.23% of US stocks have a lower such ratio.
  • AGIO's price/sales ratio is 19.54; that's higher than the P/S ratio of 93.17% of US stocks.
  • As for revenue growth, note that AGIO's revenue has grown 50.87% over the past 12 months; that beats the revenue growth of 89.78% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Agios Pharmaceuticals Inc, a group of peers worth examining would be BPMC, RARE, DRNA, PRNB, and RGNX.
  • Visit AGIO's SEC page to see the company's official filings. To visit the company's web site, go to
AGIO Daily Price Range
AGIO 52-Week Price Range

AGIO Stock Price Chart More Charts

AGIO Price/Volume Stats

Current price $50.66 52-week high $54.68
Prev. close $49.57 52-week low $27.77
Day low $48.27 Volume 522,898
Day high $51.22 Avg. volume 721,090
50-day MA $44.07 Dividend yield N/A
200-day MA $41.88 Market Cap 3.49B

Agios Pharmaceuticals, Inc. (AGIO) Company Bio

Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. The company was founded in 2007 and is based in Cambridge, Massachusetts.

AGIO Latest News Stream

Event/TimeNews Detail
Loading, please wait...

AGIO Latest Social Stream

Loading social stream, please wait...

View Full AGIO Social Stream

Latest AGIO News From Around the Web

Below are the latest news stories about Agios Pharmaceuticals Inc that investors may wish to consider to help them evaluate AGIO as an investment opportunity.

Why Is Agios Pharmaceuticals (AGIO) Up 25.8% Since Last Earnings Report?

Agios Pharmaceuticals (AGIO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Investment Research | May 30, 2020

Agios Presents Updated Data from the Phase 1 Dose-escalation Study of Vorasidenib in Patients with IDH-mutant Non-enhancing Glioma

– Vorasidenib Demonstrated Prolonged Disease Control and Encouraging Preliminary Activity with Median Progression-free Survival of 31.4 Months – – Vorasidenib Demonstrated a.

Yahoo | May 29, 2020

Moving Average Crossover Alert: Agios Pharmaceuticals

Agios Pharmaceuticals, Inc. (AGIO) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Zacks Investment Research | May 28, 2020

Is Agios Pharmaceuticals (AGIO) Stock Outpacing Its Medical Peers This Year?

Is (AGIO) Outperforming Other Medical Stocks This Year?

Zacks Investment Research | May 21, 2020

Agios Announces Publication of TIBSOVO® Phase 3 Data in The Lancet Oncology Demonstrating Significant Improvement in Progression-Free Survival Compared to Placebo in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients

– TIBSOVO® Is the First and Only IDH1 Inhibitor to Be Evaluated in a Phase 3 Clinical Trial for IDH1-Mutant Cholangiocarcinoma – CAMBRIDGE, Mass., May 19, 2020 -- Agios.

Yahoo | May 19, 2020

Read More 'AGIO' Stories Here

AGIO Price Returns

1-mo 28.87%
3-mo 8.02%
6-mo 20.71%
1-year 1.32%
3-year 0.36%
5-year -58.38%
YTD 6.09%
2019 3.56%
2018 -19.35%
2017 37.00%
2016 -35.72%
2015 -42.06%

Continue Researching AGIO

Want to see what other sources are saying about Agios Pharmaceuticals Inc's financials and stock price? Try the links below:

Agios Pharmaceuticals Inc (AGIO) Stock Price | Nasdaq
Agios Pharmaceuticals Inc (AGIO) Stock Quote, History and News - Yahoo Finance
Agios Pharmaceuticals Inc (AGIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9901 seconds.